T-cell replete haploidentical bone marrow transplantation and post-transplant cyclophosphamide for patients with inborn errors

Παρόμοια τεκμήρια

• Cytomegalovirus viremia, disease, and impact on relapse in T-cell replete peripheral blood haploidentical hematopoietic cell transplantation with post-transplant cyclophosphamide
  ανά: Goldsmith, Scott R., κ.ά.
  Έκδοση: (2016)
• Myeloablative Conditioning with PBSC Grafts for T Cell-Replete Haploidentical Donor Transplantation Using Posttransplant Cyclophosphamide
  ανά: Solomon, Scott R., κ.ά.
  Έκδοση: (2016)
• Caspofungin for primary antifungal prophylaxis after T‐cell–replete haploidentical stem cell transplantation with post‐transplant cyclophosphamide
  ανά: Mariotti, Jacopo, κ.ά.
  Έκδοση: (2019)
• Infections after T‐replete haploidentical transplantation and high‐dose cyclophosphamide as graft‐versus‐host disease prophylaxis
  ανά: Crocchiolo, R., κ.ά.
  Έκδοση: (2015)
• HLA-haploidentical blood or marrow transplantation with high-dose, post-transplantation cyclophosphamide
  ανά: Fuchs, EJ
  Έκδοση: (2015)